Skip to main content

Table 2 Serum PSA, Testosterone, and Cholesterol Before and During Study

From: Phase II trial of isoflavone in prostate-specific antigen recurrent prostate cancer after previous local therapy

Pt No. PSA at entry (ng/ml) PSA at 12 months (ng/ml) Free PSA at entry (ng/ml) Free PSA at 12 months (ng/ml) Testosterone at entry (ng/ml) Testosterone at 12 months (ng/ml) Free Testosterone at entry (ng/ml) Free Testosterone at 12 months (ng/ml) Cholesterol at entry (mg/dl) Cholesterol at 12 months (mg/dl)
1 0.57 1.93 0.10 0.381 493 468 N/A 10.1 195 207
2 0.50 0.35 0.08 0.007 331 382 46.7 8.5 148 134
3 1.76 1.62 N/A N/A 259 263 11.9 N/A 229 N/A
4 1.17 N/A 0.11 N/A 508 N/A 9.3 N/A 109 N/A
5 6.87 11.23 N/A 1.690 324 299 N/A 5.7 203 173
6 5.94 13.41 0.83 2.250 N/A 418 N/A 9.7 140 134
7 1.18 1.73 N/A 0.280 264 118 N/A 5.5 162 141
8 0.67 N/A 0.08 N/A 264 N/A 10.2 N/A 167 N/A
9 0.15 0.12 0.01 N/A 68 68 3.4 N/A 260 197
10 0.4 N/A N/A N/A 360 N/A N/A N/A N/A N/A
11 18.86 N/A N/A N/A 137 N/A 4.6 N/A 199 N/A
12 11.21 N/A 1.49 N/A 204 N/A N/A N/A 134 N/A
13 0.74 0.67 0.07 N/A 565 N/A 15.6 N/A 319 N/A
14 3.49 3.90 0.22 3.902 280 265 10.4 9.7 151 145
15 1.36 1.59 N/A N/A 521 487 19.3 N/A 255 235
16 0.50 0.50 N/A 0.020 N/A 281 N/A 12.0 N/A 200
17 2.67 5.15 0.15 0.290 287 382 9.8 0.9 180 170
18 0.59 1.10 N/A 0.100 333 317 4.0 47.6 147 163
19 1.04 N/A N/A N/A N/A N/A N/A N/A N/A N/A
20 0.79 1.05 N/A N/A 299 N/A 10.5 N/A 116 171
Median 1.11 1.61 0.11 0.19 299 308 10.3 9.7 167 171
P value 0.081 0.285 0.064 0.031 0.806
\